ERBB2 and breast cancer: Furthermore, these compounds are implicated in the stimulation of ER-negative BC cells proliferation, including HER2+ and TN BC cells, through a mechanism associated with the activation of different growth factor receptors and mitogenic signaling pathways [11,14,15].